Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 26, Issue 5, 1987, Pages 676-686

  ZAMETKIN, ALAN J ^a   RAPOPORT, JUDITH L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Attention Deficit Disorder; Hyperactivity; pharmacology

Indexed keywords

CENTRAL STIMULANT AGENT; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT;

ATTENTION DEFICIT DISORDER; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HYPERACTIVITY; PSYCHOLOGICAL ASPECT; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; HUMAN; NEUROTRANSMITTERS;

EID: 0346801189     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-198709000-00011     Document Type: Article

References (102)

1. the effect of stimulants and methylphenidate on secretion of growth hormone in hyperactive children
2. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine
3. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle
4. A review of stimulant drug research with hyperactive children
5. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents -in hyperactive children
6. The behavior of children receiving Benzedrine
7. Urinary 3-methoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children
8. Aggression, Suicide and serotonin: relationships to CSF amine metabolites
9. Plasma levels of d-amphetamine in hyperactive children
10. D & L amphetamine stereo-isomers: comparative potencies in affecting the firing of central dopaminergic and nor adrenergic neurons
11. Hyperactive children's event-related potentials fail to support underarousal and maturational-lag-theories
12. Stimulants
13. Computed tomographic brain scanning in children with developmental Neuropsychiatric disorders
14. Frontal lobe disinhibition in attention deficit disorder
15. Serotonin concentrations in whole blood of hyperactive children
16. Effects of meth-Maze performance in emotionally disturbed children
17. Treatment of hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response
18. Specific learning disabilities: an attentional deficit syndrome
19. Plasma free and total tryptophan, blood serotonin and the hyperactivity syndrome: no evidence for serotonin deficiency hypothesis
20. Imaging opiate receptors in the human brain by positron tomography
21. Comparative effects of pemoline, amfoelic acid, and amphetamine on dopamine uptake and release in vitro on brain 3, 4-dihydroxy-phenylacetic acid concentration on spiperone-treated rats
22. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
23. Comparative effects of methylphenidate and thioridazine in hyperkinetic children
24. A comparison of the vascular dopamine receptor with other dopamine receptors
25. Disinhibitory psychopathology: a new perspective and a model for research
26. Noradrenergic nervous activity in migraine
27. Use of blood serotonin levels for the classification and treatment of hyperactive behavior disorders
28. Depressed 5-hydroxyindolactic levels associated with hyperactive and aggressive behavior
29. Prolactin, growth hormone, and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate
30. Neuropharmacology of methylphenidate and a neural substitute for childhood hyperactivity
31. Clinical studies of methylphenidate serum levels in children and adults
32. Antidepressant drugs affect dopamine uptake
33. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo crossover therapeutic trial
34. Differential effects of selected dopaminergic agonists on locomotor activity in normal and spontaneously hypertensive rats
35. Tryptophan metabolism in children with attention deficit disorder
36. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome
37. Hyperkinesis and organicity in children
38. Psychoactive drugs in the immature organism
39. Biochemical actions of amphetamines and other stimulants
40. Hemispheric asymmetries and the cortical localization of higher cognitive and affective functions
41. Developmental changes in the neurotransmitter properties of dissociated sympathetic neurons: a cytochemical study of the effects of medium
42. Evidence for neurotransmitter plasticity in vivo: developmental changes in properties of cholinergic sympathetic neurons
43. Behavioral effects of carbidopa/levodopa in hyperactive bosy
44. Pilot trial of mianserin hydrochloride for childhood hyperactivity
45. Hyperkinetic impulsive disorder in children's behavior problems
46. Forebrain norepinephrine and the selective processing of information
47. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder
48. Relationship between central nervous system noradrenergic function and plasma and urinary MHPG and other norepinephrine metabolites
49. Noradrenaline and spatial memory
50. The role of frontal lobe dysfunction in childhood hyperkinesis
51. The hyperactive child syndrome. Peripheral sympatheic nervous system function and the effect of d'amphetamine
52. Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-β-hydroxylase immunohistochemistry
53. Clinical and laboratory studies with selective monoamine oxidase inhibiting drugs. Implications for hypothetical neurotransmitter changes associated with depression and antidepressant drug effects
54. Cortical atrophy in young adults
55. Amino acid supplementation as therapy for attention deficit disorder
56. Effect of chronic desipramine treatment on adrenoceptor modulation of ['H]dopamine release from rat nucleus accumbens slices
57. Behavioral assessment of Psychostimulant effects on ADD children in a summer day treatment program
58. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain
59. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients
60. Dose dependent effects and acute amphetamine administration on functional brain metabolism I rats
61. Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate: relevance to its action in hyperactive children
62. Selective antidepressants lack specificity n norepinephrine and serotonin metabolites in cerebrospinal fluid
63. Urinary catecholamine and amphetamine excretion in hyperactive and normal boys
64. Imipramine and methylphenidate treatments of hyperactive boys
65. Platelet serotonin of hyperactive school age boys
66. Pharmacokinetics of pemoline in hyperactive children
67. Electrodermal correlates of hyperactivity in children
68. CCSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine
69. Attention deficit disorder. Quantitative analysis of CT
70. Selective brain dopamine depletion in developing rats. An experimental model of minimal brain dysfunction
71. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine and behavioral measures following acute and chronic treatment with methylphenidate
72. Platelet MAO in children with attention deficit disorder and hyperactivity. A pilot study
73. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine
74. (). Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine
75. Urinary MHPG and HVA exeretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine
76. Central monoamines and hyperactivity of childhood
77. Neuropharmacological basis of stimulant drug action in attention deficit disorder within hyperactivity: a review and synthesis
78. Positron emission tomography in the newborn: extensive impairment of regional cerebral blood flow with intraventricular hemorrhage and hemorrhage intracerebral involvement
79. Platelet scrotonin level in children with “minimal brain dysfunction.”
80. The minimal brain dysfunction syndrome in children
81. Urinary monoamine metabolites in children with minimal brain dysfunction
82. Some clinical and laboratory studies of psychotropic drugs in children: an overview
83. Studies on the hyperactive child: III, the effect of chlorpromazine upon behavior and learning ability
84. Antipsychotics (major tranquilizers, neuroleptics)
85. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
86. Platelet monomine oxidase activity in children and adolescents with psychiatric disorders
87. Urinary 3-methoxy-4-hydroxy-phenylglycol sulfate excretion in seventy-three school children with minimal brain dysfunction syndrome
88. Phenylethylamine excretion in attention deficit disorder
89. Stimulants, urinary catecholamines and indoleamines in hyperactivity: a comparison of methylphenidate and dextroamphetamine
90. The pathophysiology of attention deficit disorder with hyperactivity: a review
91. Treatment of hyperactive children with monoamine oxidase inhibitors: II. Plasma and urinary monamine findings after treatment
92. Treatment of hyperactive children with monoamine oxidase inhibitors: I. clinical efficacy